S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

Podcast

In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

Watch the full interview here.

Recent Videos
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
The importance of nipocalimab’s FTD against FNAIT | Image Credit: linkedin.com
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Related Content
Image credit: © Aquir - stock.adobe.com

FDA approves oral sulopenem for treatment of uncomplicated UTIs

Morgan Ebert, Managing Editor
October 25th 2024
Article

Iterum Therapeutics has announced the FDA has approved ORLYNVAH (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs)

Read More

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Lindsey Carr, Editor
December 22nd 2022
Podcast

This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Listen

Contemporary OB/GYN week in review: Anemia, cardiovascular risks, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Anemia, cardiovascular risks, and more

Celeste Krewson, Assistant Editor
October 18th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

Lindsey Carr, Editor
December 21st 2022
Podcast

This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Listen

RE104 aims to become the first psychedelic to treat postpartum depression

RE104 aims to become the first psychedelic to treat postpartum depression

Kevin Kunzmann
October 16th 2024
Article

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

Read More

Contemporary OB/GYN week in review: Elinzanetant, breast cancer, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: Elinzanetant, breast cancer, and more

Celeste Krewson, Assistant Editor
October 11th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

© 2024 MJH Life Sciences

All rights reserved.